• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How to improve therapy for adult acute myeloid leukemia: studies of the AML Cooperative Group in the Federal Republic of Germany.

作者信息

Büchner T, Hiddemann W, Maschmeyer G, Ludwig W, Löffler H, Nowrousian M, Aul C, Heinecke A

机构信息

Department of Internal Medicine, University of Münster, Federal Republic of Germany.

出版信息

J Cancer Res Clin Oncol. 1990;116(1):97-9. doi: 10.1007/BF01612647.

DOI:10.1007/BF01612647
PMID:2179230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12200471/
Abstract
摘要

相似文献

1
How to improve therapy for adult acute myeloid leukemia: studies of the AML Cooperative Group in the Federal Republic of Germany.如何改善成人急性髓系白血病的治疗：德意志联邦共和国急性髓系白血病协作组的研究
J Cancer Res Clin Oncol. 1990;116(1):97-9. doi: 10.1007/BF01612647.
2
Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia.低剂量高三尖杉酯碱和阿糖胞苷联合粒细胞集落刺激因子预处理对复发或难治性急性髓系白血病的疗效。
J Cancer Res Clin Oncol. 2011 Jun;137(6):997-1003. doi: 10.1007/s00432-010-0947-z. Epub 2010 Dec 9.
3
The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety.CPX-351在急性髓系白血病治疗格局中的作用：作用机制、疗效与安全性
Drugs. 2025 May 10. doi: 10.1007/s40265-025-02194-w.
4
[Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Bull Cancer. 1974 Jul-Sep;61(3):411-8.
5
Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor.用阿糖胞苷和重组人粒细胞巨噬细胞集落刺激因子治疗预后不良的新诊断急性髓系白血病。
Blood. 1990 May 1;75(9):1766-9.
6
Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia.用于预防和治疗急性髓性白血病患者感染性并发症的集落刺激因子。
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD008238. doi: 10.1002/14651858.CD008238.pub3.
7
Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapy.急性髓系白血病中对传统化疗耐药的定义：基于150例标准化一线治疗后复发患者接受硫鸟嘌呤、阿糖胞苷和柔红霉素（TAD 9）再治疗结果的提议。
Leukemia. 1990 Mar;4(3):184-8.
8
[Difficulties of remission induction treatment of acute myeloblastic leukemia].
Sem Hop. 1974 May 26;50(25):1691-4.
9
[Quality of survival in patients with acute leukemia subjected to combination drug therapy].
G Clin Med. 1976 Mar-Aug;57(5-6):183-91.
10
[Treatment of acute myeloid leukemia].[急性髓系白血病的治疗]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(2):190-200.

引用本文的文献

1
Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia.常规剂量阿糖胞苷与伊达比星治疗老年急性髓系白血病的疗效
Ann Hematol. 1994 Jun;68(6):279-83. doi: 10.1007/BF01695033.

本文引用的文献

1
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study.
Blood. 1982 Aug;60(2):454-62.
2
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.急性髓细胞白血病的治疗：B组癌症与白血病研究组的一项研究
Blood. 1981 Dec;58(6):1203-12.
3
A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia.
Blood. 1984 Apr;63(4):843-7.
4
A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial.
Blood. 1984 May;63(5):1039-45.
5
Acute myelogenous leukaemia: maintenance chemotherapy after early consolidation treatment does not prolong survival.
Lancet. 1984 Feb 18;1(8373):379-82. doi: 10.1016/s0140-6736(84)90424-0.
6
Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.
J Clin Oncol. 1985 Dec;3(12):1583-9. doi: 10.1200/JCO.1985.3.12.1583.
7
Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study.癌症与白血病B组研究：三种缓解诱导方案及两种诱导后策略治疗急性非淋巴细胞白血病的比较
Blood. 1987 May;69(5):1441-9.
8
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.雄激素、免疫疗法和化疗用于成人急性髓性白血病维持治疗的随机对照研究。欧洲癌症研究与治疗组织白血病-淋巴瘤组试验
Cancer. 1986 Aug 1;58(3):617-23. doi: 10.1002/1097-0142(19860801)58:3<617::aid-cncr2820580304>3.0.co;2-1.
9
High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia.大剂量阿糖胞苷与米托蒽醌：难治性急性髓系白血病的一种高效治疗方案。
Blood. 1987 Mar;69(3):744-9.
10
Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.维持化疗可延长成人急性非淋巴细胞白血病的缓解期。
J Clin Oncol. 1988 Apr;6(4):583-7. doi: 10.1200/JCO.1988.6.4.583.